Sepsis and cirrhosis in growing animals: description of a new experimental model and its pathological and immunological reliability

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Citação
CLINICS, v.75, article ID e1858, 8p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVES: In cirrhotic children, infection events and sepsis are more frequent and more severe due to immune dysfunction. The objectives of the current study were therefore to develop an experimental model of infection and sepsis in cirrhotic weaning growing rats, by the use of bile duct ligation (BDL) and cecal ligation and puncture (CLP). Additionally, the correlation of the clinico-histopathological data and serial cytokine levels in septic cirrhotic and non-cirrhotic animals was studied. METHODS: Young Wistar rats of age 21 days and of weight between 70-90 g were divided into 12 groups according to the surgical procedure performed: sham (sacrificed after 2 or 4 weeks), BDL (sacrificed after 2 or 4 weeks), CLP (2- or 4-week old animals sacrificed after 12 or 24 hours), BDL+CLP (2- or 4-week old animals sacrificed after 12 hours). Histopathological studies and determination of serum levels of cytokines IL-1 beta, IL10, and TNF-alpha, for studies of systemic infection, were performed. Murine sepsis scores (MSS) based on the clinical aspects just before euthanasia were also included. RESULTS: A transitory increase in IL-1, IL-10, and TNF-alpha levels was observed, with different patterns according to the groups. Two-hit groups tended to present with higher values of serum cytokines and histopathological scores than their septic non-cirrhotic counterparts. There was a correlation between mortality rate and MSS (p<0.0001). CONCLUSION: The model is feasible and may be utilized in studies on liver cirrhosis and infection in growing animals.
Palavras-chave
Cirrhosis, Immune Dysfunction, Endotoxemia, Experimental Cirrhosis, Biliary Obstruction, Biliary Cirrhosis
Referências
  1. Andrade WD, 2009, J PEDIATR SURG, V44, P2071, DOI 10.1016/j.jpedsurg.2009.05.020
  2. Tannuri ACA, 2016, CLINICS, V71, P185, DOI 10.6061/clinics/2016(04)01
  3. Arvaniti V, 2010, GASTROENTEROLOGY, V139, P1246, DOI 10.1053/j.gastro.2010.06.019
  4. Assimakopoulos SF, 2009, WORLD J GASTROENTERO, V15, P121, DOI 10.3748/wjg.15.121
  5. Bosoi CR, 2017, METAB BRAIN DIS, V32, P513, DOI 10.1007/s11011-016-9937-4
  6. Braz MJD, 2018, J PEDIATR SURG, V53, P1408, DOI 10.1016/j.jpedsurg.2017.08.012
  7. Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001
  8. DING JW, 1994, J SURG RES, V57, P238, DOI 10.1006/jsre.1994.1138
  9. DING JW, 1992, EUR J SURG, V158, P157
  10. Emr BM, 2018, SURG INFECT, V19, P176, DOI 10.1089/sur.2017.316
  11. Fallon MB, 1997, AM J PHYSIOL-GASTR L, V272, pG779
  12. Fink MP, 2008, KIDNEY INT, V74, P991, DOI 10.1038/ki.2008.442
  13. Garrido M, 2017, EUR J HISTOCHEM, V61, P249, DOI 10.4081/ejh.2017.2803
  14. Gentile LF, 2014, J IMMUNOL, V192, P3156, DOI 10.4049/jimmunol.1301726
  15. Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099
  16. KAZARIAN KK, 1994, SHOCK, V1, P201, DOI 10.1097/00024382-199403000-00008
  17. Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B
  18. Lewis AJ, 2016, SURG INFECT, V17, P385, DOI 10.1089/sur.2016.021
  19. Lo RC, 2017, CLIN MOL HEPATOL, V23, P302, DOI 10.3350/cmh.2017.0078
  20. Gibelli NEM, 2008, CLINICS, V63, P689, DOI 10.1590/S1807-59322008000500019
  21. Gibelli NEM, 2009, PEDIATR TRANSPLANT, V13, P81, DOI 10.1111/j.1399-3046.2008.00947.x
  22. Mortell A, 2006, PEDIATR SURG INT, V22, P111, DOI 10.1007/s00383-005-1593-4
  23. Ng PC, 2006, CURR OPIN PEDIATR, V18, P125, DOI 10.1097/01.mop.0000193293.87022.4c
  24. Parker SJ, 2001, BRIT J SURG, V88, P22, DOI 10.1046/j.1365-2168.2001.01632.x
  25. Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872
  26. Saito H, 2003, MECH AGEING DEV, V124, P1047, DOI 10.1016/j.mad.2003.08.002
  27. Sheen JM, 2010, J PEDIATR SURG, V45, P1650, DOI 10.1016/j.jpedsurg.2009.12.019
  28. Shrum Bradly, 2014, BMC Res Notes, V7, P233, DOI 10.1186/1756-0500-7-233
  29. Singleton KD, 2003, EUR SURG RES, V35, P486, DOI 10.1159/000073387
  30. Sipeki N, 2014, WORLD J GASTROENTERO, V20, P2564, DOI 10.3748/wjg.v20.i10.2564
  31. Standage SW, 2011, EXPERT REV ANTI-INFE, V9, P71, DOI 10.1586/ERI.10.154
  32. Starr ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115705
  33. Tannuri ACA, 2012, J PEDIATR SURG, V47, P513, DOI 10.1016/j.jpedsurg.2011.10.009
  34. Verboon-Maciolek MA, 2006, PEDIATR RES, V59, P457, DOI 10.1203/01.pdr.0000200808.35368.57
  35. WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2
  36. Xiao HY, 2006, INFECT IMMUN, V74, P5227, DOI 10.1128/IAI.01220-05